[
  {
    "ts": null,
    "headline": "2 Top AI Stocks Prominent Billionaires Are Buying",
    "summary": "Stanley Druckenmiller and Bill Ackman were buying shares of these tech giants in the second quarter.",
    "url": "https://finnhub.io/api/news?id=96fdd89e10d31c242e2e5561be927bd5536bd88407c8a3a691da74ceea2289e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756552500,
      "headline": "2 Top AI Stocks Prominent Billionaires Are Buying",
      "id": 136581214,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MSFT",
      "source": "Yahoo",
      "summary": "Stanley Druckenmiller and Bill Ackman were buying shares of these tech giants in the second quarter.",
      "url": "https://finnhub.io/api/news?id=96fdd89e10d31c242e2e5561be927bd5536bd88407c8a3a691da74ceea2289e2"
    }
  },
  {
    "ts": null,
    "headline": "Does Surgeon-Led Hemopatch Launch Mark a New Innovation Edge for Baxter (BAX)?",
    "summary": "On August 18, 2025, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad tailored for use in both open and minimally invasive surgeries, following a decade-long collaboration with medical experts. This product's development was driven by direct surgeon feedback, highlighting Baxter's approach of addressing specific, real-world clinical needs through practical innovation. We'll explore how delivering a new surgeon-informed hemostatic device could...",
    "url": "https://finnhub.io/api/news?id=7e59e2d17a51edd9d28833c26ed6c28ccce43bf5548b33a70da017ce3de2b155",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756548941,
      "headline": "Does Surgeon-Led Hemopatch Launch Mark a New Innovation Edge for Baxter (BAX)?",
      "id": 136581210,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MSFT",
      "source": "Yahoo",
      "summary": "On August 18, 2025, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad tailored for use in both open and minimally invasive surgeries, following a decade-long collaboration with medical experts. This product's development was driven by direct surgeon feedback, highlighting Baxter's approach of addressing specific, real-world clinical needs through practical innovation. We'll explore how delivering a new surgeon-informed hemostatic device could...",
      "url": "https://finnhub.io/api/news?id=7e59e2d17a51edd9d28833c26ed6c28ccce43bf5548b33a70da017ce3de2b155"
    }
  },
  {
    "ts": null,
    "headline": "How Strong Overseas Demand and New Guidance at JinkoSolar (JKS) Has Changed Its Investment Story",
    "summary": "Earlier this week, JinkoSolar Holding reported its first half 2025 operating results, revealing total module shipments of 41.8 GW, with over 60% delivered to overseas markets, and issued new shipment guidance for the third quarter and full year. This highlights the company's continued success in expanding its international footprint, providing fresh insight into demand across its global markets. We'll now explore how strong overseas demand and robust shipment guidance could influence...",
    "url": "https://finnhub.io/api/news?id=d6f56d09f0f85e80c4d3c8efe2961758b36e7743b563030a173c34422f1354a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756548663,
      "headline": "How Strong Overseas Demand and New Guidance at JinkoSolar (JKS) Has Changed Its Investment Story",
      "id": 136581211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MSFT",
      "source": "Yahoo",
      "summary": "Earlier this week, JinkoSolar Holding reported its first half 2025 operating results, revealing total module shipments of 41.8 GW, with over 60% delivered to overseas markets, and issued new shipment guidance for the third quarter and full year. This highlights the company's continued success in expanding its international footprint, providing fresh insight into demand across its global markets. We'll now explore how strong overseas demand and robust shipment guidance could influence...",
      "url": "https://finnhub.io/api/news?id=d6f56d09f0f85e80c4d3c8efe2961758b36e7743b563030a173c34422f1354a4"
    }
  },
  {
    "ts": null,
    "headline": "Intrinsic Value Is Subjective: A Big Problem And A Big Opportunity For Investors",
    "summary": "Discover why market prices deviate from intrinsic value, disproving EMH.",
    "url": "https://finnhub.io/api/news?id=8c7548e6fee21f0944ce1990205b42c8b5ab923cb216467775efcda60e12fd31",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756544700,
      "headline": "Intrinsic Value Is Subjective: A Big Problem And A Big Opportunity For Investors",
      "id": 136580579,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/652567306/image_652567306.jpg?io=getty-c-w1536",
      "related": "MSFT",
      "source": "SeekingAlpha",
      "summary": "Discover why market prices deviate from intrinsic value, disproving EMH.",
      "url": "https://finnhub.io/api/news?id=8c7548e6fee21f0944ce1990205b42c8b5ab923cb216467775efcda60e12fd31"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia is facing its biggest challenge yet: The law of large numbers",
    "summary": "Nvidia is a fast-growing and highly profitable enterprise. But that may not be enough to reward investors from here.",
    "url": "https://finnhub.io/api/news?id=5af29985ea7e86622b029ee1778f196c4eb7314819ce9169b7576055defa030e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756544400,
      "headline": "Nvidia is facing its biggest challenge yet: The law of large numbers",
      "id": 136581212,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MSFT",
      "source": "Yahoo",
      "summary": "Nvidia is a fast-growing and highly profitable enterprise. But that may not be enough to reward investors from here.",
      "url": "https://finnhub.io/api/news?id=5af29985ea7e86622b029ee1778f196c4eb7314819ce9169b7576055defa030e"
    }
  },
  {
    "ts": null,
    "headline": "Marvell: Load Up Now While The Market Runs For Cover",
    "summary": "Marvell's growth in AI infrastructure and custom chips makes it a strong investment opportunity despite recent market skepticism and valuation. See more on MRVL.",
    "url": "https://finnhub.io/api/news?id=9cd50f010d174292dfab640d9ef76633215eb812e5ae0a934437c4e8d6800a67",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756544400,
      "headline": "Marvell: Load Up Now While The Market Runs For Cover",
      "id": 136580580,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2183147259/image_2183147259.jpg?io=getty-c-w1536",
      "related": "MSFT",
      "source": "SeekingAlpha",
      "summary": "Marvell's growth in AI infrastructure and custom chips makes it a strong investment opportunity despite recent market skepticism and valuation. See more on MRVL.",
      "url": "https://finnhub.io/api/news?id=9cd50f010d174292dfab640d9ef76633215eb812e5ae0a934437c4e8d6800a67"
    }
  },
  {
    "ts": null,
    "headline": "Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition",
    "summary": "Tempus AI, Inc. (NASDAQ:TEM) is one of the best Robinhood stocks to buy right now. On August 22, the company confirmed the acquisition of Paige, an artificial intelligence company specializing in digital pathology, for $81.25 million. Founded in 2017, Paige is the owner of the first FDA-cleared AI application in pathology. It offers solutions and […]",
    "url": "https://finnhub.io/api/news?id=f5d0951769a5b19c27a764506d8810f8dfeda2da0bf6ee86a01a508d4283735c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756525372,
      "headline": "Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition",
      "id": 136579510,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MSFT",
      "source": "Yahoo",
      "summary": "Tempus AI, Inc. (NASDAQ:TEM) is one of the best Robinhood stocks to buy right now. On August 22, the company confirmed the acquisition of Paige, an artificial intelligence company specializing in digital pathology, for $81.25 million. Founded in 2017, Paige is the owner of the first FDA-cleared AI application in pathology. It offers solutions and […]",
      "url": "https://finnhub.io/api/news?id=f5d0951769a5b19c27a764506d8810f8dfeda2da0bf6ee86a01a508d4283735c"
    }
  }
]